The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Share News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Ocado Shares Up; Big AIM Risers Amid M&A

Mon, 02nd Nov 2020 11:01

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.

----------

FTSE 100 - WINNERS

----------

Ocado Group, up 8.3%. The online retailer boosted earnings guidance and unveiled two acquisitions. For the financial year to the end of November, Ocado has raised its Ebitda guidance and expects the figure to be over GBP60 million, compared to previous guidance of GBP40 million. This means a minimum of a 39% rise from GBP43.3 million the year before.

----------

J Sainsbury, up 2.6%, Tesco, up 2.4% and Just Eat Takeaway, up 2.9%. The trio are among those tipped to benefit from the latest UK lockdown. Ahead of the Spring lockdown, grocers were boosted by consumer stockpiling and food delivery firms like Just Eat Takeaway, received a helpful tailwind from restaurant restrictions that banned in-dining. Supermarkets will be allowed to stay open during the upcoming lockdown in England, and restaurants will be allowed to sell food for takeaway and delivery.

----------

FTSE 100 - LOSERS

----------

JD Sports Fashion, down 3.7%, and International Consolidated Airlines Group, down 2.9%. The non-essential retail sector will be forced to close high street units as a result of lockdown measures, hurting JD Sports, while the British Airways owner IAG will see already low levels of demand for international travel take a further hit due to the new restrictions, which ban overnight travel for non-essential reasons.

----------

FTSE 250 - WINNERS

----------

Carnival, up 6.9%. US health authorities late Friday issued a detailed set of requirements that would allow cruise ships to resume services as early as next month. The requirements for a "phased resumption" of cruise ship passenger operations were released by the US Centers for Disease Control & Prevention. This would include "simulated voyages to test cruise ship operators' ability to mitigate Covid-19 risk," the CDC said.

----------

FTSE 250 - LOSERS

----------

Serco, down 12%. The outsourcer was dealt a blow as the UK's Ministry of Defence renationalised the Atomic Weapons Establishment. AWE was managed by a joint-venture with Lockheed Martin and Jacobs since 2000. Serco and Jacobs each had a 24.5% stake in AWE and Lockheed 51%.

----------

Ibstock, down 6.2%. Deutsche Bank cut the brick maker to Hold from Buy.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Horizon Discovery, shares more than doubled. The life sciences firm agreed to a GBP296 million takeover from PerkinElmer, or 185 pence per share. Horizon shares closed at 88.8p on Friday. PerkinElmer has received irrevocable undertakings in respect to 21% of Horizon shares.

----------

LiDCO Group, up 71%. The medical devices firm agreed to a GBP31.1 million takeover from Masimo LHC. The 12p per share offer price is a 78% premium to LiDCO's 6.75p closing price on Friday. Masimo has received the support of 38% of LiDCO shares so far.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Pathfinder Minerals PLC, down 26%. Says the prospects of settling a dispute over a Mozambique licence with its former partners "have diminished" and company may seek recourse against the government of Mozambique. Pathfinder asserts Mozambique "acted improperly" and had no legal right to take away the licences from the company back in 2011.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
1 May 2018 16:15

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 2 May Direct Line Insurance GroupQ1 ResultsConvaTec GroupQ1 GroupHalf

Read more
14 Feb 2017 09:15

Horizon Discovery looks to grow revenue as it teams up with pharmaceutical

(ShareCast News) - Gene editing technology company Horizon Discovery has teamed up with a global pharmaceutical to support its drug discovery developments as it aims to increase revenue in 2017. The AIM-listed company penned a master service agreement with the pharmaceuticals adding to its original

Read more
24 Jan 2017 10:44

Horizon Discovery's full year revenue rises as volumes increase

(ShareCast News) - Horizon Discovery Group, a maker of gene editing technologies, saw revenue increased last year, driven by better-than-expected sales volumes. For the 2016 calendar year, revenue climbed 19% to £24m compared to the previous year, with gross margin increasing to the mid-50% range, f

Read more
24 Jan 2017 09:47

Horizon Discovery Targets Positive Earnings In Current Year

Read more
16 Nov 2016 10:01

Horizon Disc gains Chinese partnerships to develop tumor diagnostic kit

(ShareCast News) - Horizon Discovery, a developer of gene editing technologies, has entered into partnerships with three Chinese diagnostic kit developers to treat tumours. The company will provide HDx Reference Standards for next generation sequencing assay development, clinical trials, and for inc

Read more
19 Oct 2016 13:59

Horizon Discovery inks subscription-based licensing deal

(ShareCast News) - Horizon Discovery has inked a subscription-based licensing deal for its biomanufacturing cell lines. The deal, the first of its type for the company and with an unnamed commercial partner, is worth a minimum of £500,000. "We look forward to making further announcements in this are

Read more
19 Oct 2016 07:23

Horizon Discovery Signs Licensing Deal With GBP500,000 Minimum Value

Read more
6 Sep 2016 09:53

Horizon Discovery Inks CRISPR Platform Deal With Fulcrum Therapeutics

Read more
1 Sep 2016 11:13

Horizon Discovery signs development agreement with Ventanta

(ShareCast News) - Gene editing technologies company Horizon Discovery Group announced on Thursday that it has entered into a co-development and commercialisation agreement with Ventana Medical Systems, a member of the Roche Group. The AIM-traded firm said the agreement covers the development, manuf

Read more
17 Jun 2016 15:06

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Jun 2016 07:52

Horizon Discovery Says Qiagen Incorporates Reference Standards

Read more
12 May 2016 08:04

Horizon Discovery Signs Deals With Next Generation Sequencing Firm

Read more
11 May 2016 08:37

BROKER RATINGS SUMMARY: Jefferies And Shore Say Hold AstraZeneca

Read more
11 May 2016 07:22

LONDON BRIEFING: Compass Group Up But TUI Down Following Updates

Read more
26 Apr 2016 15:43

Revenues grow, losses widen at Horizon Discovery

(ShareCast News) - Gene-editing technology company Horizon Discovery Group saw revenues grow sizably in the 2015 calendar year, it reported on Tuesday, though losses also widened. The AIM-traded firm reported a 69% increase in total group revenue to £20.2m, with product revenues growing 124% to £7.8

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.